Chad Pecot, MD, is a UNC Lineberger Comprehensive Cancer Center member specializing in solid tumor malignancies, thoracic medical oncology and clinical research. MD Professor, …

In collaboration with our Carolina Center of Cancer Nanotechnology Excellence, I am studying how nanoparticle-based platforms can be exploited to target the metastatic process. Currently …

Plastic Engineering Company of Tulsa, Inc. We are a privately-held corporation continuously owned by the same family dating back to our inception in 1945. Since 1970 the company has …

2022年3月15日 · Chad Pecot, MD, and colleagues revealed how they used tissue and tumor specimens from a patient just after he succumbed to lung cancer to unravel how a KRAS …

We are always looking for dynamic, bright and engaging people to join our team. Because we take a team science approach, we are especially looking for scientists interested in working …

My research is characterized by a harmonization of therapeutic RNA interference, sophisticated modeling of cancer metastasis and the tumor microenvironment, and the integrative use of …

My research is characterized by a harmonization of therapeutic RNA interference, sophisticated modeling of cancer metastasis and the tumor microenvironment, and the integrative use of …

2021年4月9日 · With more than 1.5 million people in the U.S. diagnosed with cancer in 2019 alone, Chad Pecot is determined to make a lasting impact on the lives of those going through …

CV Pecot, FZ Bischoff, JA Mayer, KL Wong, T Pham, J Bottsford-Miller, ... Cancer discovery 1 (7), 580-586, 2011. 232: 2011: Role of focal adhesion kinase in regulating YB–1–mediated …